Our startup specializes in the cutting-edge field of extracellular vesicle (EV) biomarker discovery, utilizing single EV analysis and machine learning to revolutionize precision medicine. We provide a novel platform that significantly enhances the sensitivity and specificity of biomarker identification and allows healthcare professionals to diagnose conditions at an early stage, facilitating timely and personalized treatment options. We are committed to improving patient outcomes by bridging critical gaps in current diagnostic biomarkers. Our approach holds the potential to transform therapeutic strategies across a spectrum of diseases. With a focus on innovation and a strong IP strategy, we aim to lead the market in delivering robust and data-driven solutions for biomarker discovery.
12.01.2026
Life sciences and cleantech startups compete for CHF 100,000 (startupticker.ch)
22.08.2025
DayOne Accelerator reveals latest cohort (startupticker.ch)
27.12.2024
CHF 150,000 from Venture Kick to bring precision diagnostics to cancer immunotherapies (startupticker.ch)
21.05.2024
Venture Leaders Biotech scale new heights in Boston (venturelab.swiss)
17.05.2024
EVIIVE: The Venture Leader Biotech developing the next-generation liquid biopsy solution (venturelab.swiss)
01.01.2024
Eviive appoints Sandeep Wontakal MD. PhD as clinical & medical advisor
01.08.2023
Eviive received Innosuisse initial coaching award
Research / Fulltime
EVIIVE is seeking a detail-oriented Clinical Research Associate to join their Zurich-based team, where they are pioneering the use of extracellular vesicles and machine learning to transform diagnostics in immuno-oncology and neurology. In this role, you will bridge the gap between cutting-edge research and clinical application by overseeing sample logistics, managing ethics compliance, and coordinating with hospital partners and CROs to ensure the integrity of validation studies. Ideal for a professional with 1–3 years of experience and a strong grasp of GCP, this position offers the chance to work within a cross-disciplinary team on high-impact projects such as predicting immunotherapy responses, while providing flexible Swiss-based working arrangements and clear pathways for growth in clinical operations.
Advisor / Parttime
EVIIVE is looking for a Regulatory Affairs Lead to spearhead the compliance strategy for their breakthrough liquid biopsy platform, navigating the complex transition from R&D to clinical application. In this pivotal role, you will define the regulatory roadmap across Swiss, EU, and US jurisdictions, managing critical documentation for IvDO, IVDR, and FDA pathways while supporting ISO 13485 alignment. Ideal for an independent expert with over 3 years of experience in diagnostics, this position offers the high-impact opportunity to work directly with founders in a lean, mission-driven startup environment, with the flexibility of part-time or consultancy arrangements and the potential for equity.
Research / Internship
EVIIVE is offering a hands-on internship for Master’s students in biology or bioengineering to help pioneer the next generation of extracellular vesicle (EV) diagnostics within the fields of immuno-oncology and neurology. Working at the intersection of immunobiology and machine learning, you will contribute to real-world R&D projects by assisting with sample processing, EV isolation, and flow cytometry to discover high-impact immune biomarkers. This role provides a unique opportunity to receive direct mentorship from experienced scientists and founders while gaining exposure to a cutting-edge liquid biopsy platform designed to provide clinicians with the clarity needed for faster, more personalized medical interventions.
No videos and documents
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
eviive.ch
Headquarter:
Obfelden
Foundation Date:
November 2024
Technology:
Sectors: